FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to F respiratory syncytial virus (hereinafter – RSV) protein mutants, to vaccines against RSV, containing F RSV protein mutants, as well as to a method for the prevention of RSV infection in a human by administration of the above-mentioned vaccine.
EFFECT: mutants of F protein, according to the present invention, allow for obtainment of effective vaccines against RSV.
18 cl, 9 dwg, 23 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROTEIN F RSV MUTANTS | 2016 |
|
RU2723039C2 |
| RSV F MUTANT PROTEIN AND ITS APPLICATION | 2020 |
|
RU2807742C1 |
| ANTIGENIC POLYPEPTIDES BASED ON THE RESPIRATORY SYNCYTIAL VIRUS SEQUENCE | 2019 |
|
RU2807992C2 |
| ENGINEERED MULTI-SPECIFIC ANTIBODIES AND OTHER MULTIMERIC PROTEINS WITH ASYMMETRIC MUTATIONS IN THE CH2-CH3 REGION | 2018 |
|
RU2804031C2 |
| RSV PROTEINS IN PRE-CONFLUENCE CONFORMATION AND USE THEREOF | 2014 |
|
RU2761631C2 |
| STABILIZED F RSV PROTEINS AND THEIR USE | 2019 |
|
RU2795459C2 |
| MULTIVALENT PD-L1-BINDING COMPOUNDS FOR TREATING MALIGNANT NEOPLASMS | 2020 |
|
RU2816646C2 |
| EMBODIMENTS OF IGG-Fc FOR USE IN VETERINARY SCIENCE | 2018 |
|
RU2814952C2 |
| SUBUNIT VACCINE FOR TREATING OR PREVENTING RESPIRATORY TRACT INFECTION | 2020 |
|
RU2811991C2 |
| POLYVALENT AND POLYSPECIFIC GITR-BINDING FUSED PROTEINS | 2016 |
|
RU2753439C2 |
